The diagnostic chain reported Rs 29 crore net profit in the corresponding quarter of the previous year.
Revenue from operations grew by 13.1% YoY to Rs 313.4 crore.
The earnings for interest, tax, depreciation and ammortisation (EBITDA) before CSR and ESOP rose 20.2% YoY to Rs 80.5 crore in Q1. The EBITDA margin in Q1FY25 was 25%.
Growth in patient volumes and test volumes stood at 7% and 10%, respectively for the quarter. Revenue per patient increased by 6%.”Our TruHealth (Wellness and Bundling) segment grew by 28% this quarter, which has helped us move the customers up the value chain, resulting in an increase in revenue per patient,” said Ameera Shah, executive chairperson and whole-time director, Metropolis Healthcare.”We are confident that network expansion, increased footfalls, and a shift in test mix will continue to help us achieve our desired growth,” Shah added.Metropolitan has a network of 204 labs, 4216 collection centres and over 10,000 touch points.
